Credit Suisse Ag Mannkind Corp Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Mannkind Corp stock. As of the latest transaction made, Credit Suisse Ag holds 365,353 shares of MNKD stock, worth $2.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

365,353

Previous 365,353 -0.0%

Holding current value

$2.22 Million

Previous $1.33 Million 24.53%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$3.34 - $4.29 $270,042 - $346,850	80,851 Added 28.42%	365,353 $1.33 Million
Q3 2023 Nov 13, 2023	SELL	$3.91 - $5.45 $176,082 - $245,435	-45,034 Reduced 13.67%	284,502 $1.17 Million
Q2 2023 Aug 11, 2023	BUY	$3.72 - $4.79 $329,603 - $424,408	88,603 Added 36.77%	329,536 $1.34 Million
Q1 2023 May 10, 2023	BUY	$3.95 - $5.63 $256 - $365	65 Added 0.03%	240,933 $987,000
Q4 2022 Feb 13, 2023	BUY	$3.02 - $5.37 $54,550 - $96,998	18,063 Added 8.11%	240,868 $1.27 Million
Q3 2022 Nov 10, 2022	BUY	$2.99 - $4.35 $73,117 - $106,374	24,454 Added 12.33%	222,805 $688,000
Q2 2022 Aug 12, 2022	BUY	$2.67 - $4.77 $12,743 - $22,767	4,773 Added 2.47%	198,351 $756,000
Q1 2022 May 16, 2022	SELL	$2.62 - $4.45 $9,657 - $16,402	-3,686 Reduced 1.87%	193,578 $713,000
Q4 2021 Feb 14, 2022	SELL	$4.05 - $5.37 $84,361 - $111,857	-20,830 Reduced 9.55%	197,264 $863,000
Q3 2021 Nov 12, 2021	BUY	$3.89 - $5.48 $69,000 - $97,204	17,738 Added 8.85%	218,094 $949,000
Q2 2021 Aug 16, 2021	BUY	$3.61 - $5.45 $626,800 - $946,278	173,629 Added 649.64%	200,356 $1.09 Million
Q1 2021 May 14, 2021	SELL	$3.14 - $6.14 $450,156 - $880,242	-143,362 Reduced 84.29%	26,727 $104,000
Q4 2020 Feb 12, 2021	BUY	$1.79 - $4.04 $286,548 - $646,735	160,083 Added 1599.87%	170,089 $533,000
Q3 2020 Nov 13, 2020	SELL	$1.56 - $2.08 $22,651 - $30,201	-14,520 Reduced 59.2%	10,006 $19,000
Q2 2020 Aug 12, 2020	BUY	$0.94 - $2.21 $23,054 - $54,202	24,526 New	24,526 $43,000
Q1 2020 May 13, 2020	SELL	$0.84 - $1.76 $13,776 - $28,865	-16,401 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$1.14 - $1.49 $29,462 - $38,507	-25,844 Reduced 61.18%	16,401 $21,000
Q3 2019 Nov 12, 2019	BUY	$1.04 - $1.44 $10,116 - $14,006	9,727 Added 29.91%	42,245 $53,000
Q2 2019 Aug 14, 2019	SELL	$1.09 - $1.88 $5,348 - $9,225	-4,907 Reduced 13.11%	32,518 $37,000
Q1 2019 May 14, 2019	BUY	$1.14 - $2.25 $11,387 - $22,475	9,989 Added 36.41%	37,425 $74,000
Q4 2018 Feb 13, 2019	BUY	$1.02 - $2.05 $13,312 - $26,754	13,051 Added 90.73%	27,436 $29,000
Q3 2018 Nov 13, 2018	SELL	$1.01 - $2.19 $27,447 - $59,515	-27,176 Reduced 65.39%	14,385 $26,000
Q2 2018 Aug 14, 2018	BUY	$1.59 - $2.38 $66,081 - $98,915	41,561 New	41,561 $79,000

Others Institutions Holding MNKD

# of Institutions

244

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account